Latest Breaking News On - Matt scalo - Page 1 : comparemela.com

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

SALT LAKE CITY, June 03, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College.

San antonioUnited statesDale muzzeyAllison kurianGlenn farrellMatt scaloExchange commissionStanford university school of medicineAmerican college of medical geneticsGenetics incAmerican collegeMedical geneticsHereditary cancerSpotlight presentationAntonio breast cancer symposiumMyrisk hereditary cancer test

Genetics in Medicine Publishes Myriad Genetics

SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today.

San antonioUnited statesMatt scaloDale muzzeyGlenn farrellAllison kurianGenetics incStanford university school of medicineAmerican college of medical geneticsExchange commissionAmerican collegeMedical geneticsHereditary cancerSpotlight presentationAntonio breast cancer symposiumMyrisk hereditary cancer test

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJohn gilardiLisa mannagotteraThomas theuringerMatt scaloGlenn farrellMychoice cdxDomenica martoranaFernando beilsPatrick burkeUs securities exchangeLife sciencesExchange commissionFrankfurt prime standardMyriad geneticsHomologous recombination deficiency

QIAGEN and Myriad Genetics develop distributable homologous

QIAGEN and Myriad Genetics develop distributable homologous
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesMatt scaloLisa mannagotteraThomas theuringerJohn gilardiDomenica martoranaMychoice cdxGlenn farrellPatrick burkeFernando beilsUs securities exchangeLife sciencesExchange commissionFrankfurt prime standardMyriad geneticsHomologous recombination deficiency

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven

Salt lake cityUnited statesGeorge daneker jrMatt scaloBracanalysis cdxHollyj pedersonGlenn farrellBreast servicesOncology solutionsMemorial sloan kettering cancer centerCollaborative research registryGenetics incNational cancer center hospitalExchange commissionUniversity of texas md anderson cancer centerA myriad collaborative research registry study